^
Association details:
Biomarker:No biomarker
Cancer:Brain Cancer
Drug:lomustine (Alkylating agent)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A1 - Approval
New
Source:
Excerpt:
Gleostine is an alkylating drug indicated for the treatment of patients with...Brain tumors, primary and metastatic, following appropriate surgical and/or radiotherapeutic procedures.